Article by Dylan Klimchuk, Cannabis Life Network
Vancouver-based health care company Numinus Bioscience has officially harvested the first legal batch of Psilocybe mushrooms in Canada by a public company. The announcement came only a few months after the company amended its Health Canada-issued Controlled Drugs and Substances Dealer’s Licence to allow researchers to conduct research to standardize the extraction of psilocybin from mushrooms. The license also permits the company to test, import and export, store, and distribute MDMA, Psilocybin, Psilocin, DMT, and Mescaline.
A natural source of high-quality psilocybin is of great benefit to both researchers and potential patients of the developing form of medicine. Natural psilocybin extracts are likely to be far more affordable compared to their synthetic counterparts. With its new supply, Numinus seeks to develop safe, evidence-based, accessible psychedelic-assisted psychotherapy through extensive research and development.